An Antimicrobial susceptibility study to compare the in vitro activity of antimicrobial agents in the Philippines against Enterobacterales and Pseudomonas aeruginosa from different infection sites: results from ATLAS surveillance program (2018–2021)

Myrna Mendoza, Evelina Lagamayo, Marie Yvette Barez, Vaidehi Wadhwa, Evan Payawal

Open source

DOI
10.1186/s12879-026-13396-2
Published
2026-05-10
Container
BMC Infectious Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12879-026-13396-2,
  title = {An Antimicrobial susceptibility study to compare the in vitro activity of antimicrobial agents in the Philippines against Enterobacterales and Pseudomonas aeruginosa from different infection sites: results from ATLAS surveillance program (2018–2021)},
  author = {Myrna Mendoza and Evelina Lagamayo and Marie Yvette Barez and Vaidehi Wadhwa and Evan Payawal},
  year = {2026},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/s12879-026-13396-2},
  url = {https://doi.org/10.1186/s12879-026-13396-2}
}

RIS

TY  - JOUR
TI  - An Antimicrobial susceptibility study to compare the in vitro activity of antimicrobial agents in the Philippines against Enterobacterales and Pseudomonas aeruginosa from different infection sites: results from ATLAS surveillance program (2018–2021)
AU  - Myrna Mendoza
AU  - Evelina Lagamayo
AU  - Marie Yvette Barez
AU  - Vaidehi Wadhwa
AU  - Evan Payawal
PY  - 2026
JO  - BMC Infectious Diseases
DO  - 10.1186/s12879-026-13396-2
UR  - https://doi.org/10.1186/s12879-026-13396-2
ER  - 

APA

Mendoza, M., Lagamayo, E., Barez, M. Y., Wadhwa, V., & Payawal, E. (2026). An Antimicrobial susceptibility study to compare the in vitro activity of antimicrobial agents in the Philippines against Enterobacterales and Pseudomonas aeruginosa from different infection sites: results from ATLAS surveillance program (2018–2021). BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-13396-2

Source records